Literature DB >> 11753023

Testing for malignant hyperthermia.

Henry Rosenberg1, Joseph F Antognini, Sheila Muldoon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11753023     DOI： 10.1097/00000542-200201000-00036

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  6 in total

Review 1.  [Malignant hyperthermia].

Authors:  T Metterlein; F Schuster; B M Graf; M Anetseder
Journal:  Anaesthesist       Date:  2014-12       Impact factor: 1.041

Review 2.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.

Authors:  Stephen G Gonsalves; Robert T Dirksen; Katrin Sangkuhl; Rebecca Pulk; Maria Alvarellos; Teresa Vo; Keiko Hikino; Dan Roden; Teri E Klein; S Mark Poler; Sephalie Patel; Kelly E Caudle; Ronald Gordon; Barbara Brandom; Leslie G Biesecker
Journal:  Clin Pharmacol Ther       Date:  2019-01-24       Impact factor: 6.875

3.  A case report of malignant hyperthermia in a dental clinic operating room.

Authors:  M Cynthia Fukami; Steven I Ganzberg
Journal:  Anesth Prog       Date:  2005

Review 4.  Personalized pediatric anesthesia and pain management: problem-based review.

Authors:  Senthil Packiasabapathy; Valluvan Rangasamy; Nicole Horn; Michele Hendrickson; Janelle Renschler; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2020-01       Impact factor: 2.533

5.  Genetically Confirmed Malignant Hyperthermia in a Six-Week-Old Infant: A Case Report.

Authors:  Christopher M Edwards; Thomas K Jenkins; Nikolaus Gravenstein; Amy M Gunnett; Timothy W Martin
Journal:  Cureus       Date:  2022-07-19

6.  Voltage modulates halothane-triggered Ca2+ release in malignant hyperthermia-susceptible muscle.

Authors:  Alberto Zullo; Martin Textor; Philipp Elischer; Stefan Mall; Andreas Alt; Werner Klingler; Werner Melzer
Journal:  J Gen Physiol       Date:  2017-12-15       Impact factor: 4.086
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.